Strategic report Governance & remuneration Financial statements Investor information 31 Net debt continued Current assets Long-term borrowings Liquid investments are classied as available-for-sale investments.
At the year-end, GSK had long-term borrowings of 15.3 billion At 31 December 2015, they included US Treasury Notes and 2014 15.8 billion of which 10 billion 2014 9.8 billion other government bonds.
The effective interest rate on liquid falls due in more than five years.
The average effective pre-swap investments at 31 December 2015 was approximately 0.7% interest rate of all notes in issue at 31 December 2015 was 2014 approximately 0.3%.
Liquid investment balances at approximately 3.9% 2014 approximately 3.8%.
31 December 2015 earning interest at oating rates amount to Long-term borrowings repayable after five years carry interest 4 million 2014 69 million.
Liquid investment balances at at effective rates between 1.49% and 6.39%.
The repayment 31 December 2015 earning interest at xed rates amount to dates range from 2022 to 2045.
Pledged assets The effective interest rate on cash and cash equivalents at The Group has pledged investments in US Treasury Notes with 31 December 2015 was approximately 1.3% 2014 a par value of $105 million 71 million, 2014 $105 million approximately 1.6%.
Cash and cash equivalents at 67 million as security against irrevocable letters of credit 31 December 2015 earning interest at oating and xed rates issued on the Groups behalf in respect of the Groups selfamount to 5,654 million and nil respectively 2014 insurance activity.
Provisions in respect of self-insurance are 4,243 million and 1 million.
included within the provisions for legal and other disputes GSKs policy regarding the credit quality of cash and cash discussed in Note 29, Other provisions.
In addition, 37 million equivalents is referred to in Note 41, Financial instruments 2014 32 million of assets included in Note 22, Other and related disclosures.
non-current assets, which do not form part of Net debt, were pledged as collateral against future rental payments under Short-term borrowings operating lease arrangements entered into by Human Genome GSK has a $10 billion 6.8 billion US commercial paper Sciences, Inc. prior to its acquisition by the Group.
programme which was undrawn at 31 December 2015 2014 $1.0 billion 0.7 billion drawn.
GSK also has 1.9 billion five year committed medium-term facilities and $2.5 billion 1.7 billion of 364 day committed facilities.
These facilities were put in place in September 2015 and were undrawn at 31 December 2015.
Liquid investments, cash and cash equivalents were as shown in the table on page 178.
The weighted average interest rate on current bank loans and overdrafts at 31 December 2015 was 3.49% 2014 4.28%.
2015 2014 Finance lease obligations m m Rental payments due within one year 25 31 Rental payments due between one and two years 21 23 Rental payments due between two and three years 15 19 Rental payments due between three and four years 6 13 Rental payments due between four and five years 6 3 Rental payments due after five years 4 2 Total future rental payments 77 91 Future finance charges 7 6 Total finance lease obligations 70 85 32 Contingent liabilities At 31 December 2015, contingent liabilities, comprising guarantees, discounted bills and other items arising in the normal course of business, amounted to 200 million 2014 185 million.
At 31 December 2015, nil 2014 nil of financial assets were pledged as collateral for contingent liabilities.
Provision is made for the outcome of tax, legal and other disputes where it is both probable that the Group will suffer an outow of funds and it is possible to make a reliable estimate of that outow.
At 31 December 2015, other than for those disputes where provision has been made, it was not possible to make a reliable estimate of the potential outow of funds that might be required to settle disputes where the possibility of there being an outow was more than remote.
Descriptions of the significant tax, legal and other disputes to which the Group is a party are set out in Note 14, Taxation and Note 45, Legal proceedings.
